Chinese female breast cancer patients show a better overall survival than their male counterparts.
Xia
Liang-ping
LP
State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, China. xialiangping@163.com
Zhou
Fei-fei
FF
Guo
Gui-fang
GF
Wang
Fang
F
Wang
Xi
X
Yuan
Zhong-yu
ZY
Zhang
Bei
B
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D018567:Breast Neoplasms, Male / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D002681:China; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D012727:Sex Characteristics; D015996:Survival Rate
D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; C508053:ERBB2 protein, human